Revenue increased by +5.6% year-on-year due to company-wide optimization and reallocation of growth investments; operating income exceeded plan at +8.2%. Strong growth in Healthcare and expanded new customer acquisition, with investments focused on Fun and Health driving profits. The plan for the fiscal year ending September 2027 targets revenue of 46,000 hundred million yen and operating income of 5,400 hundred million yen. The mid-term plan Growth Next 2027 will continue investing centered on Healthcare growth, and pursue M&A and new brand development.<\/p>\n","protected":false},"comment_status":"open","ping_status":"closed","template":"","meta":{"Ticker":"","DATE":"","longName":"","company_name_ja":"","fullTimeEmployees":0,"address":"","phone":"","website":"","industry":"","sector":"","regularMarketPrice":0,"financialCurrency":"","marketCap":0,"fiftyTwoWeekLow":0,"fiftyTwoWeekHigh":0,"epsTrailingTwelveMonths":0,"epsForward":0,"bookValue":0,"totalRevenue":0,"OperatingIncome":0,"operatingMargins":0,"NetIncome":0,"profitMargins":0,"ebitda":0,"trailingPE":0,"forwardPE":0,"priceToBook":0,"returnOnEquity":0,"recommendationMean":0,"recommendationKey":"","targetMeanPrice":0,"numberOfAnalystOpinions":0,"analyst_earnings_data":"","dividendRate":0,"dividendYield":0,"payoutRatio":0,"totalEsg":0,"environmentScore":0,"socialScore":0,"governanceScore":0,"title":"","providerPublishTime":"","link":"","longBusinessSummary":"","longBusinessSummary_ja":"","quarterly_revenue":0,"quarterly_net_income":0,"quarterly_operating_profit":0,"enterprise_value":0,"price_fetched_at":"","company_officer_1_name":"","company_officer_1_title":"","company_officer_2_name":"","company_officer_2_title":"","company_officer_3_name":"","company_officer_3_title":"","company_officer_4_name":"","company_officer_4_title":"","company_officer_5_name":"","company_officer_5_title":"","company_officers_update_time":"","get_dividend_history_year1":0,"get_dividend_history_year2":0,"get_dividend_history_year3":0,"get_dividend_history_year4":0,"get_dividend_history_year5":0,"get_dividend_history_year6":0,"get_dividend_history_year7":0,"get_dividend_history_year8":0,"get_dividend_history_year9":0,"get_dividend_history_year10":0,"site-sidebar-layout":"default","site-content-layout":"","ast-site-content-layout":"","site-content-style":"default","site-sidebar-style":"default","ast-global-header-display":"","ast-banner-title-visibility":"","ast-main-header-display":"","ast-hfb-above-header-display":"","ast-hfb-below-header-display":"","ast-hfb-mobile-header-display":"","site-post-title":"","ast-breadcrumbs-content":"","ast-featured-img":"","footer-sml-layout":"","theme-transparent-header-meta":"","adv-header-id-meta":"","stick-header-meta":"","header-above-stick-meta":"","header-main-stick-meta":"","header-below-stick-meta":"","astra-migrate-meta-layouts":"default","ast-page-background-enabled":"default","ast-page-background-meta":{"desktop":{"background-color":"var(--ast-global-color-5)","background-image":"","background-repeat":"repeat","background-position":"center center","background-size":"auto","background-attachment":"scroll","background-type":"","background-media":"","overlay-type":"","overlay-color":"","overlay-opacity":"","overlay-gradient":""},"tablet":{"background-color":"","background-image":"","background-repeat":"repeat","background-position":"center center","background-size":"auto","background-attachment":"scroll","background-type":"","background-media":"","overlay-type":"","overlay-color":"","overlay-opacity":"","overlay-gradient":""},"mobile":{"background-color":"","background-image":"","background-repeat":"repeat","background-position":"center center","background-size":"auto","background-attachment":"scroll","background-type":"","background-media":"","overlay-type":"","overlay-color":"","overlay-opacity":"","overlay-gradient":""}},"ast-content-background-meta":{"desktop":{"background-color":"var(--ast-global-color-4)","background-image":"","background-repeat":"repeat","background-position":"center center","background-size":"auto","background-attachment":"scroll","background-type":"","background-media":"","overlay-type":"","overlay-color":"","overlay-opacity":"","overlay-gradient":""},"tablet":{"background-color":"var(--ast-global-color-4)","background-image":"","background-repeat":"repeat","background-position":"center center","background-size":"auto","background-attachment":"scroll","background-type":"","background-media":"","overlay-type":"","overlay-color":"","overlay-opacity":"","overlay-gradient":""},"mobile":{"background-color":"var(--ast-global-color-4)","background-image":"","background-repeat":"repeat","background-position":"center center","background-size":"auto","background-attachment":"scroll","background-type":"","background-media":"","overlay-type":"","overlay-color":"","overlay-opacity":"","overlay-gradient":""}},"jir_stock_code":"4931","jir_company_name":"Shinnihonseiyaku Co., Ltd.","jir_importance":"\u2605\u2605\u2605\u2605\u2606","jir_publication_date":"2026-11-11","jir_source_link":"https:\/\/japanir.jp\/wp-content\/uploads\/2026\/11\/4931-20261111-03.pdf","jir_short_summary":"Revenue increased by +5.6% year-on-year due to company-wide optimization and reallocation of growth investments; operating income exceeded plan at +8.2%. Strong growth in Healthcare and expanded new customer acquisition, with investments focused on Fun and Health driving profits. The plan for the fiscal year ending September 2027 targets revenue of 46,000 hundred million yen and operating income of 5,400 hundred million yen. The mid-term plan Growth Next 2027 will continue investing centered on Healthcare growth, and pursue M&A and new brand development.","jir_summary":"### Overview of Results\nFor the fiscal year ended September 2026, revenue was 43,455 hundred million yen, up +5.6% year-on-year, and operating income was 5,176 hundred million yen, up +8.2% year-on-year, achieving profit growth exceeding the Growth Next 2027 plan. Although the Cosmetics segment fell short of plan in certain respects, company-wide revenue increased driven by solid Healthcare growth and the effects of investments in Fun and Health. Marketing investments were reallocated with emphasis on ROI, and strengthening growth brands was the primary driver.\n\n### Outlook and Mid-term Plan Direction\nThe full-year plan for the fiscal year ending September 2027 assumes revenue of 46,000 hundred million yen and operating income of 5,400 hundred million yen. The company will continue growth investments in the Healthcare domain and aim to accelerate Fun and Health. Conversely, a reallocation of advertising investment for PERFECT ONE is expected to constrain growth in Cosmetics. Under the Growth Next 2027 mid-term management plan, expanding the Healthcare foundation is the top priority, and the company plans to expand the portfolio through new brand development and M&A.","jir_financial_highlights":"Revenue: 43,455 hundred million yen (Year-over-Year +5.6%)\nOperating Income: 5,176 hundred million yen (Year-over-Year +8.2%)\nNet Income Attributable to Owners of Parent: 3,400 hundred million yen (Year-over-Year +37.3%)\nInitial Plan Revenue under Mid-term Plan Growth Next 2027: 46,000 hundred million yen (Expected Year-over-Year +5.9%)\nROE: 13.7% (Actual (FY 26\/9))","jir_category":"","jir_hashtags":"#Shinnihonseiyaku, #Earnings, #GrowthNext2027, #Healthcare, #DigitalMarketing","jir_key_figures":"Revenue 43,455 hundred million yen (Year-over-Year +5.6%)\nOperating Income 5,176 hundred million yen (Year-over-Year +8.2%)\nNet Income Attributable to Owners of Parent 3,400 hundred million yen (Year-over-Year +37.3%)","jir_meta_title":"Shinnihonseiyaku Co., Ltd. Accelerating Healthcare Growth under Growth Next\uff5cSupplementary FY2026 Results","jir_meta_description":"Supplementary materials for Shinnihonseiyaku Co., Ltd.'s fiscal year ended September 2026. Revenue 43,455 hundred million yen, operating income 5,176 hundred million yen; explains Healthcare growth, expansion of new customers, and FY2027 plan of 46,000 hundred million yen revenue and 5,400 hundred million yen operating income. Summarizes Growth Next 2027 strategy.","jir_og_title":"Shinnihonseiyaku Co., Ltd. to Accelerate Healthcare Growth in Results Supplement","jir_og_description":"Supplementary presentation for Shinnihonseiyaku Co., Ltd.'s fiscal year ended September 2026. Significant Healthcare growth and new customer acquisition; FY2027 targets revenue 46,000 hundred million yen and operating income 5,400 hundred million yen.","jir_og_image_url":"\/assets\/og\/company-financial_summary.jpg","jir_chart_data_collection":"[{\"jir_chart_id\": \"revenue_trend\", \"jir_chart_type\": \"line\", \"jir_chart_title\": \"Revenue Trend\", \"jir_chart_json_data\": \"{\\\"type\\\":\\\"line\\\",\\\"data\\\":{\\\"labels\\\":[\\\"25\/9\u671f\\\",\\\"26\/9\u671f\\\"],\\\"datasets\\\":[{\\\"label\\\":\\\"Revenue\\\",\\\"data\\\":[431.4,434.55]}]},\\\"options\\\":{}}\"}, {\"jir_chart_id\": \"operating_profit_trend\", \"jir_chart_type\": \"line\", \"jir_chart_title\": \"Operating Income Trend\", \"jir_chart_json_data\": \"{\\\"type\\\":\\\"line\\\",\\\"data\\\":{\\\"labels\\\":[\\\"25\/9\u671f\\\",\\\"26\/9\u671f\\\"],\\\"datasets\\\":[{\\\"label\\\":\\\"Operating Income\\\",\\\"data\\\":[47.82,51.76]}]},\\\"options\\\":{}}\"}, {\"jir_chart_id\": \"segment_revenue_breakdown\", \"jir_chart_type\": \"bar\", \"jir_chart_title\": \"Segment Revenue Breakdown\", \"jir_chart_json_data\": \"{\\\"type\\\":\\\"bar\\\",\\\"data\\\":{\\\"labels\\\":[\\\"Healthcare\\\",\\\"Cosmetics\\\",\\\"Mail-order\\\"],\\\"datasets\\\":[{\\\"label\\\":\\\"Revenue\\\",\\\"data\\\":[12.442,31.012,39.217]}]},\\\"options\\\":{}}\"}, {\"jir_chart_id\": \"margin_analysis\", \"jir_chart_type\": \"bar\", \"jir_chart_title\": \"Gross Margin and SG&A Composition\", \"jir_chart_json_data\": \"{\\\"type\\\":\\\"bar\\\",\\\"data\\\":{\\\"labels\\\":[\\\"Gross Margin\\\",\\\"FF Cost\\\",\\\"Advertising Expense\\\"],\\\"datasets\\\":[{\\\"label\\\":\\\"Amount\\\",\\\"data\\\":[47.8,4.04,12.78]}]},\\\"options\\\":{}}\"}, {\"jir_chart_id\": \"guidance_comparison\", \"jir_chart_type\": \"bar\", \"jir_chart_title\": \"Comparison of Forecast and Actuals\", \"jir_chart_json_data\": \"{\\\"type\\\":\\\"bar\\\",\\\"data\\\":{\\\"labels\\\":[\\\"Actual FY26\/9\\\",\\\"Plan FY27\/9\\\"],\\\"datasets\\\":[{\\\"label\\\":\\\"Revenue\\\",\\\"data\\\":[434.5,460]}]},\\\"options\\\":{}}\"}]","ir_related_company":17566,"ir_release_date":"","ir_type":"","ir_is_new":false,"ir_document_url":"","jir_ir_type":"financial_summary","footnotes":""},"sector":[],"importance":[],"class_list":["post-149199","ir_release","type-ir_release","status-publish","hentry"],"yoast_head":"\n